Contact us

Our Team

An exceptional team of Market Access experts.

INBEEO-Inbeeo_Favicon-Full-CLR-RGB

Our team genuinely care about each project they undertake, and we hold ourselves accountable to meet our partner’s needs and goals.

Hervé Lilliu

CEO

Hervé Lilliu

During a career split between industry and consulting, Hervé has gained a deep understanding of the key challenges faced by innovative life science companies. He has sharpened his tools while holding key leadership positions including Chief Access Officer, Global Marketing Head, and Affiliate President at Pfizer and UCB across 5 geographies in Europe and North America. He is a recognized thought leader in market access and pricing strategy development. He is passionate about creating novel value creation approaches in areas such as rare diseases, ATMPs, and digital therapeutics. Hervé holds a BSc in Data Science and an MSc in Health Economics both from PSL-Paris Dauphine University.
Send me an email

Erin Haney

Director

Erin Haney

Erin brings extensive pricing and market access experience, having worked with pharmaceutical and biotechnology companies to develop strategies for securing patient access to innovative therapies across a wide therapeutic spectrum. She began her career conducting clinical research, focusing on aging research before transitioning into consultancy. Since then, she has worked across various disciplines including medical communications, HEOR, and primarily pricing and market access in areas such as CNS, autoimmune, rare diseases, and ATMPs. Erin holds an MPH from Imperial College London and a BSc in Life Sciences from McMaster University, Canada, providing her with the academic foundation and deep understanding of the pharmaceutical landscape, enabling her to navigate it effectively.
Send me an email

Charlotte Langbo

Associate Director

Charlotte Langbo

Charlotte brings a diversified background in pan-life cycle commercial and access strategy to the team at Inbeeo. She has extensive experience across the strategy consulting realm, from early product planning to life cycle management strategy across rare disease, oncology, neurology, and immunology therapeutic areas. Specific to market access and pricing, Charlotte has supported gene therapy and rare disease assets in navigating regulatory and HTA landscapes, crafting pricing strategies, and building access roadmaps. Charlotte studied Biochemistry at the University of Notre Dame (USA) and prior to consultancy, has experience working in a UK non-profit health organization and within the US pharmaceutical industry.
Send me an email

Hollie Singleton

Manager

Hollie Singleton

Hollie has extensive and diverse experience across the pharmaceutical industry, from setting up early-stage clinical trials, through to market access and commercialisation of products. Within market access, Hollie has supported various types of projects, including the development of strategic partnerships for improved access, payer & policy landscape assessments, cost-effectiveness and budget impact modelling, and value messaging development. She has worked across a multitude of therapeutic areas, including rare disease, oncology, neurology, immunology, and sexual health. Hollie holds an BSc in Psychology from the University of Sussex, and is completing her MSc in Public Health at the London School of Hygiene and Tropical Medicine. Prior to her work in consultancy, Hollie worked within the pharmaceutical industry.
Send me an email

Vian van der Berg

Finance & Operations Manager

Vian van der Berg

With 35 years of experience in business management across seven different industries within the SME service sector, Vian brings a wealth of expertise in general business operations, finance, management reporting, and contract/commercial negotiation (both buy and sell side). He leverages these skills to enhance operational efficiency in support of strategic decision-making to drive sustainable growth and profitability across multiple workstreams.
Send me an email

Tania Savant

Senior Consultant

Tania Savant

Tania has focused her career at Inbeeo on the delivery of complex market access strategies and value strategy development for early assets, with a key focus on ATMPs and orphan drugs, across Europe, North America, and Japan. She applies her experience and expertise from her academic years where she conducted research focused on the development of novel gene therapy tools for the treatment of rare neurological disorders. Tania graduated from the University of St Andrews, with a first-class degree in Neuroscience and a MSc from UCL in Clinical Neuroscience.
Discover one of my projects

Lucy Forrester

Senior Consultant

Lucy Forrester

Lucy has 4 years’ experience in market access consulting. She holds a BSc in Biomedical Sciences and a Masters in Bioscience Enterprise both from University of Auckland, New Zealand. She has experience across market access strategy, payer engagement, landscape analyses as well as systematic literature reviews to support global HTA submissions. She has delivered projects across a range of disease areas including oncology, immunology, rare diseases and diagnostic imaging.
Discover one of my projects

Sara Cueva Oemer

Senior Consultant

Sara Cueva Oemer

Sara applies her previous experience in Market Intelligence and Strategy in Life Sciences academic publishing to the Market Access field to deliver value and pricing strategy projects, mainly focusing on Europe, the US and Japan. In her role, Sara leads projects spanning from payer research to landscape and analogue analyses across a variety of pharmaceutical products in rare, metabolic, CNS and oncology diseases. Sara has expertise related to the impact of regulatory updates in the EU on the EU HTA landscape. She holds an MSc Public Health from LSHTM and an MA Psychology from the University of Edinburgh
Discover one of my projects

Romario Bailey

Consultant

Romario Bailey

Romario has been developing his expertise in Market Access consulting, particularly focusing on landscape assessments, and pricing and reimbursement projects for rare diseases and vaccines. His experience includes understanding and navigating the healthcare and pharmaceutical policy landscape across major EU markets and Latin America. Romario holds an MSc in Global Health Policy from the London School of Economics and Political Science, complemented by a BSc in Biomedical Science from Anglia Ruskin University. He is excited about building on his scientific and industry knowledge to enhance access to innovative medicines and technologies across diverse populations and contexts.
Send me an email

Sama Seyedmousavi

Consultant

Sama Seyedmousavi

During her time at Inbeoo, Sama assisted clients in understanding early and alternative access opportunities for drugs across five regions, conducting landscape assessments for various markets, and market access and pricing strategies. She has experience in analogue assessment and life cycle management strategies. Additionally, she has contributed to policy projects involving changes in EU pharma legislation and cost-containment measures across Europe. Sama possesses extensive knowledge of innovative therapies such as Cell and Gene therapies, acquired through her MRes in Biomedical Research and MSc in Genes, Drugs, and Stem Cells from Imperial College. She also holds an MSc in Stem Cells and Regenerative Medicine from King's College , alongside a BSc in Economics
Discover one of my projects

Natalia Ravingerova

Senior Associate

Natalia Ravingerova

Natalia recently completed an MSc in Pharmaceutical Formulation and Entrepreneurship from University College London with Distinction. She holds a First Class Honours degree in Neuroscience from the University of Edinburgh. Before joining Inbeeo, she gained valuable experience in the pharmaceutical industry through an internship in regulatory affairs. Natalia is passionate about innovation in the healthcare sector and is committed to leveraging her knowledge to support the development and implementation of market access strategies at Inbeeo.
Send me an email

Sonnika Lamont

Senior Associate

Sonnika Lamont

Sonnika is a strategic life sciences professional, bringing expertise in market access, pricing, and value strategy to global pharmaceutical and biotech clients. She has supported projects across the asset lifecycle in Europe, North America, and Asia-Pacific, delivering market assessments, analogue analyses, HTA evidence synthesis, and value communication. She translated complex data into actionable insights for senior stakeholders, with a focus on rare diseases and oncology. She earned a First-Class BSc in Biochemistry from Nottingham Trent University and an MRes in Drug Design with Distinction from University College London, building a strong research and analytical foundation for her work in the pharmaceutical industry.
Send me an email

Lucrezia Della Loggia

Associate

Lucrezia Della Loggia

During her time at Inbeeo,Lucrezia has developed expertise in early and alternative access pathways for innovative medicinal products across five regions: Europe, North America, LATAM, APAC, and MENAT. She has conducted primary and secondary research to evaluate the price potential of new assets and has gained insight into the reimbursement processes for low- and middle-income countries (LMICs) for strategic planning. Additionally, she has experience with advisory boards. Lucrezia holds a BSc in Biomedical Sciences from Royal Holloway, University of London and an MSc in Drug Discovery and Pharmaceutical Management from University College London.
Discover one of my projects

James Kuwornu

Associate

James Kuwornu

James graduated in 2024 from the University of Nottingham with an Integrated MSci in Pharmaceutical Sciences. Alongside his final year he completed a placement year at GSK in their Global Health Unit with a focus on their Access Programmes. During this he achieved a First Class Dissertation investigating "Sustainable Alternatives to Donation Programmes for the Elimination of Neglected Tropical Diseases in Africa". Prior to this James has experience working in an NHS consultancy rolling out Digital First Primary Care for practices in London.
Send me an email

Christel Jansen

Senior External Partner

Christel Jansen

Christel is a seasoned value, access, and policy consultant, dedicated to enhancing patient access to cutting-edge treatments. Her professional journey began as a global health and health system strengthening policy advisor, collaborating closely with ministries of health across diverse nations. Upon transitioning into strategy consulting, Christel has amassed profound expertise in crafting market access strategies, developing value communication that resonates with key stakeholders, and shaping access policies with external stakeholders. Her work has covered various therapeutic areas, including oncology, rare diseases, advanced therapy medicinal products (ATMPs), and medical devices/SAMDs. Christel earned her Masters Degree in Medicine and Political Sciences (International Relations) from VU University in Amsterdam.
Send me an email

Jean-Marc Frybourg

Senior Consultant

Jean-Marc Frybourg

A graduate of ESCP-Europe and holding a Masters in Market Research and Marketing Strategy, Jean-Marc has 30 years of experience in the broader pharmaceutical industry – including biologics and animal health. After 9 years in pharmaceutical marketing, he gained a Masters in Health Economics at Paris Dauphine University in 1995. Since then, Jean-Marc held various Local, Regional and Global positions encompassing pricing and reimbursement, HEOR, health policy, and government affairs (Novartis, Sanofi Pasteur Vaccines, Pfizer, Shire, Merck, Indivior). Jean-Marc brings experience gained over a vast number of pricing and market access challenges ranging from identifying value for early R&D projects, to protecting products from price erosion during late-stage commercialisation.
Discover one of my projects

Realize the true value of your healthcare assets. Get started with Inbeeo today.